Literature DB >> 26454345

The role of imaging in the diagnosis and management of renal stone disease in pregnancy.

G Masselli1, M Weston2, J Spencer2.   

Abstract

The distinction of pain in pregnancy due to urolithiasis from that related to physiological dilation of the renal tract is a common conundrum as renal colic is one of the commonest causes for non-obstetric pain in pregnancy. Ultrasound is the first-line imaging test but although it may demonstrate renal dilation, it may not show the cause. Magnetic resonance imaging (MRI) is able to make the distinction. Physiological dilation will show smooth tapering of the ureter in the middle third as it is compressed between the gravid uterus and the retroperitoneum. Obstruction due to calculi causes renal enlargement and perinephric oedema. When a stone is lodged in the lower ureter, a standing column of dilated ureter will be seen below the physiological constriction. The stone itself may be shown. Computed tomography (CT) is an acceptable alternative if there is a contraindication to MRI, but even low-dose regimes involve some ionising radiation. This paper serves to highlight the role of MRI compared to US and CT in the imaging of renal colic in pregnancy. Multidisciplinary collaboration between obstetricians, urologists, and radiologists is required for effective management.
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26454345     DOI: 10.1016/j.crad.2015.09.002

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  2 in total

Review 1.  Imaging of flank pain: readdressing state-of-the-art.

Authors:  Priyanka Jha; Brian Bentley; Spencer Behr; Judy Yee; Ronald Zagoria
Journal:  Emerg Radiol       Date:  2016-09-10

2.  Risk factors of uterine contraction after ureteroscopy in pregnant women with renal colic.

Authors:  Chunjing Li; Liwen Guo; Mi Luo; Mingjuan Guo; Jierong Li; Shilin Zhang; Guoqing Liu
Journal:  Int Urol Nephrol       Date:  2021-07-05       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.